Quince Therapeutics's latest marketcap:
As of 07/17/2026, Quince Therapeutics's market capitalization has reached $18.26 M. According to our data, Quince Therapeutics is the 38213th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 18.26 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -36,155,000 |
| Shares Out | 977,962 |
| EPS (ttm) | -137.27 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/10/2026 |
Quince Therapeutics's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/17/2026 | $18.26 M | -91.86% | 38213 |
| 12/31/2025 | $186.53 M | 126.7% | 26705 |
| 12/31/2024 | $82.28 M | 82.8% | 24576 |
| 12/29/2023 | $45.01 M | 95.46% | 28472 |
| 12/30/2022 | $23.03 M | -93.89% | 31844 |
| 12/31/2021 | $377.06 M | -53.99% | 15100 |
| 12/31/2020 | $819.45 M | -45.64% | 8916 |
| 12/31/2019 | $1.51 B | n/a |
Company Profile
About Quince Therapeutics, Inc.
Quince Therapeutics, Inc. is a biopharmaceutical company dedicated to acquiring, developing, and commercializing innovative therapeutics for patients suffering from debilitating and rare diseases.
Key Focus Areas
- Lead Asset: EryDex, a promising candidate for treating rare pediatric neurodegenerative diseases, including Ataxia-Telangiectasia (A-T), an inherited disorder caused by mutations in the ATM gene.
- AIDE Technology Platform: A cutting-edge drug/device combination platform that automates the encapsulation of drugs into a patient’s red blood cells. The platform includes:
- Automated equipment (RCL)
- Sterile single-use consumable treatment kits (EryKit, Syringe Kit)
- Drugs and process solutions
Company Background
Formerly known as Cortexyme, Inc., the company rebranded as Quince Therapeutics, Inc. in August 2022. Founded in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
Frequently Asked Questions
-
What is Quince Therapeutics's (QNCX) current market cap?As of 07/17/2026, Quince Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $18.26 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Quince Therapeutics (QNCX) rank globally by market cap?Quince Therapeutics global market capitalization ranking is approximately 38213 as of 07/17/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.